GoKawiil
Tech News
A phase III trial of intismeran, a personalized cancer vaccine developed by Merck and Moderna, showed that melanoma patients who received it had longer recurrence-free survival than those given a placebo. The double-blind study of more than 1,100 participants builds on an earlier phase II trial with 157 patients and moves the vaccine closer to regulatory approval.
Following news that two unvaccinated people in Lancaster County, Pennsylvania—including a newborn—died of measles, Health Secretary Robert F. Kennedy Jr. posted a series of anti-vaccine claims on social media, attacking the MMR vaccine and Governor Josh Shapiro. He also suggested, citing a local Republican commissioner's disputed claim, that the deaths might have been fabricated by the governor's staff. These are the first measles deaths in Pennsylvania in 35 years and the first in the US in 2026, amid a national outbreak that has reached nearly 2,800 cases, the worst since 1991.
Singer Dolly Parton has died at age 80, remembered for her philanthropic contributions to science alongside her music career. She provided early funding for Moderna's vaccine research and publicly received her own COVID-19 vaccination to counter public hesitancy, while her Imagination Library program continues distributing over three million books monthly to children worldwide.
A study of more than 70,000 people published in Nature Medicine found that those who received the current Shingrix shingles vaccine, rather than an older formulation, had a reduced risk of heart disease and heart failure. Researchers compared recipients of the two vaccine types rather than vaccinated versus unvaccinated people, a design meant to avoid the bias seen in earlier studies where healthier people were more likely to get vaccinated.
Country music legend Dolly Parton has died at age 80 following a brief battle with cancer, her representatives announced. Beyond her decade-spanning music career and 10 Grammy wins, Parton was widely recognized for her philanthropic support of medical research, including a $1 million donation that helped fund Moderna's COVID-19 vaccine development at Vanderbilt University Medical Center. She also lent her name, indirectly, to Dolly the sheep, the first mammal cloned from an adult cell.
This bibliography compiles foundational studies establishing systems vaccinology, a field using genomics and machine learning to predict and understand vaccine-induced immunity in humans. Key cited works include the 2009 study by Querec and colleagues, which first showed that blood transcriptional signatures could predict antibody responses to the yellow fever vaccine, and related papers on multilineage immune activation and pandemic vaccine response variability.
Chinese biotech firms and health-tech companies are increasingly partnering with low- and middle-income countries across Africa, Asia and Latin America, supplying vaccines, medical equipment financing and digital-health systems. Examples include equipment financing in Kenya and Côte d'Ivoire, pharmaceutical production in Zambia, and vaccine supply to Indonesia and Mexico during the pandemic. These bilateral deals are emerging as traditional multilateral aid budgets shrink worldwide.
A free interactive tool called 'What's the Risk?' launched in early August, letting users visually compare the risks of vaccines against the diseases they prevent, as well as everyday hazards like car crashes, drowning and lightning strikes. It was built by the University of Minnesota's Center for Infectious Disease Research and Policy alongside Unbiased Science, a public health platform led by scientist Jessica Steier. Currently it covers measles, MMR vaccine and RSV-related products, with plans to expand comparisons over time.
The Department of Health and Human Services under Secretary Robert F. Kennedy Jr. has issued a Request for Information exploring changes to how vaccines are classified as routine, risk-based, or subject to shared clinical decision-making. No formal rule changes have been made yet, but the 10-page document invites public comment through September 20 on potential new labels that could sound more conditional than current designations.